ArticleJACC. Case reports2026
Pericardial Hemangioma: An 8-Year Diagnostic Odyssey of Recurrent Pleural Effusion.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- When the Effusion Is Not the Disease: Lessons From a Hidden Pericardial Hemangioma.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPericardial hemangioma is a rare benign tumor that can mimic chronic inflammatory disease. Distinguishing it from other pericardial masses is critical to avoiding a diagnostic delay. CASE SUMMARY: A 54-year-old woman presented with an 8-year history of recurrent effusions and was initially thought to have amyloidosis. Cardiac magnetic resonance (CMR) imaging identified a transverse pericardial sinus mass with characteristic T2 hyperintensity and centripetal enhancement, strongly suggesting hemangioma, which was confirmed histologically. Surgical excision was curative, with no recurrence at the 4-year follow-up. DISCUSSION: This case illustrates the "satisfaction of search" bias causing an 8-year diagnostic delay. It highlights the central role of comprehensive CMR tissue characterization in evaluating rare pericardial tumors, and the risk of anchoring on potentially misleading histopathological findings. TAKE-HOME MESSAGES: Pericardial hemangioma should be considered in unexplained recurrent effusions, particularly when corticosteroid therapy paradoxically reduces fluid volume and extensive autoimmune and oncologic work-up is unrevealing. Comprehensive CMR with tissue characterization is the key noninvasive modality, although histology remains confirmatory. A prior pericardial window may convert episodic pericardial effusion into chronic, treatment-refractory pleural disease by creating a preferential drainage pathway into the left pleural space.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.